LicianPro

GTBP news · GTBP stock

GT Biopharma Reports Third Quarter 2026 Financial Results

Yahoo Finance · Nov 16, 2026 · GT Biopharma Inc (GTBP)

Phase 1 trial evaluating GTB-3650 TriKE® remains ongoing, with an update anticipated in Q4 2026 Phase 1 basket trial evaluating GTB-5550 TriKE® in multiple solid tumor types known to express B7-H3 remains ongoing, with an update anticipated in Q4 2026 FDA clearance of a new IND for GTB-5550 in multiple myeloma under an investigator sponsored trial protocol; Phase 1 trial initiation contingent upon timing and receipt of non-dilutive grant funding Oral presentation at the SITC 2026 Annual Meeting

Original at Yahoo Finance

Not investment advice. Headline and summary only, not a full reprint.